Anthem Biosciences Ltd.

Anthem Biosciences stock surged nearly 27% on its market debut, trading at Rs 723.10 on BSE. The IPO was subscribed 63.86 times, with strong institutional participation. Learn more about the...

Anthem Biosciences' Rs 3,395 crore IPO was subscribed 63.86 times, exceeding expectations. QIBs showed strong interest, while the overall subscription was driven by institutional investors.

Anthem Biosciences' Rs 3,395 crore IPO is fully subscribed on day 2. Details on subscription across investor categories and offer details.

Anthem Biosciences IPO received 73% subscription on Day 1, with strong interest from non-institutional investors. The '3,395-crore IPO closes July 16.

Anthem Biosciences raises Rs 1,016 crore from anchor investors ahead of its IPO. The IPO opens July 14-16, with a price band of Rs 540-570 per share.

Kshema Power secures order for 33 kV/220 kV AIS power substation for a 350 MW wind-solar hybrid project in Madhya Pradesh.

Alembic Pharmaceuticals receives USFDA approval for generic Loteprednol Etabonate & Tobramycin ophthalmic suspension for eye infections.

Equity mutual funds see a 21% rise in inflows to Rs 29,911 crore in November. AUM rises, but SIP inflows soften. Debt funds see outflow.

Indian envoy to Canada meets with Canadian officials to enhance bilateral ties, focusing on parliamentary cooperation and immigration.

Opening bullion rates in Chennai on December 11th. Check gold and silver prices per gram for 22Kt, 18Kt gold and silver.

Kshema Power secures order for 33 kV/220 kV AIS power substation for a 350 MW wind-solar hybrid project in Madhya Pradesh.

Sudha Murty urges recognition for social innovators in Rajya Sabha, highlighting their impact and advocating for a dedicated award line.

Sarbananda Sonowal flags off India's first indigenous hydrogen fuel-cell vessel in Varanasi. A step towards green energy.

Alembic Pharmaceuticals receives USFDA approval for generic Loteprednol Etabonate & Tobramycin ophthalmic suspension for eye infections.

Equity mutual funds see a 21% rise in inflows to Rs 29,911 crore in November. AUM rises, but SIP inflows soften. Debt funds see outflow.